| ²é¿´: 576 | »Ø¸´: 2 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
yin198716гæ (ÕýʽдÊÖ)
|
[ÇóÖú]
·ÒëÇóÖú
|
||
| What about the ways of DLL4 targeting? As mentioned above, one of them is specific targeting using anti-DLL4 antibodies. Unlike ¦Ã-secretase inhibitors, anti-DLL4 antibodies did not induce gastrointestinal toxicity. They have no discernible impact on goblet cell differentiation or crypt progenitor cell proliferation. Hoey et al. found that selective antihuman antibody 21M18 inhibited expression of Notch target genes including HES1 and ATOH1, which in effect caused a low level of malignant cell proliferation . |
» ²ÂÄãϲ»¶
Çóµ÷¼ÁÍÆ¼ö
ÒѾÓÐ3È˻ظ´
085400µç×ÓÐÅÏ¢Àࣨ´¨´ó¿ØÖƹ¤³Ì£©Çóµ÷¼Á¿É¿çרҵ ÇóÀÏʦÁªÏµ
ÒѾÓÐ6È˻ظ´
²ÄÁϹ¤³Ì281»¹Óе÷¼Á»ú»áÂð
ÒѾÓÐ42È˻ظ´
290µ÷¼ÁÉúÎï0860
ÒѾÓÐ36È˻ظ´
273Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
ҩѧ305Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
Çóµ÷¼ÁѧУ
ÒѾÓÐ12È˻ظ´
ɽ¶«Ê¡»ù½ð2026
ÒѾÓÐ8È˻ظ´
ÇóÖúµ÷¼Á£¬¿çµ÷
ÒѾÓÐ19È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ13È˻ظ´

RXMCDM
°æÖ÷ (ÎÄ̳¾«Ó¢)
- ·ÒëEPI: 530
- Ó¦Öú: 401 (˶ʿ)
- ¹ó±ö: 1.908
- ½ð±Ò: 38947.6
- É¢½ð: 4908
- ºì»¨: 88
- ɳ·¢: 4
- Ìû×Ó: 11453
- ÔÚÏß: 1355.6Сʱ
- ³æºÅ: 2739168
- ×¢²á: 2013-10-20
- ÐÔ±ð: GG
- רҵ: Ò»°ã¹ÜÀíÀíÂÛÓëÑо¿·½·¨ÂÛ
- ¹ÜϽ: ÂÛÎÄ·Òë
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï
yin198716: ½ð±Ò+5, ·ÒëEPI+1 2014-02-24 15:34:00
yin198716: ½ð±Ò+5, ·ÒëEPI+1 2014-02-24 15:34:00
|
DLL4°ÐÏò·½Ê½ÊÇÔõôÑùµÄ£¿ÈçÉÏËùÊö£¬ÆäÖÐÖ®Ò»ÊÇÌØ¶¨µÄ¿¹DLL4¿¹Ìå°ÐÏò¡£Óë¦Ã-·ÖÃÚøÒÖÖÆÒò×Ó²»Í¬£¬¿¹DLL4¿¹Ìå²»ÓÕµ¼Î¸³¦µÀ¶¾ÐÔ¡£ËûÃǶԱ״ϸ°û·Ö»¯»òÒþÎÑ×æÏ¸°ûµÄÔöֳûÓÐÃ÷ÏÔµÄÓ°Ïì¡£HoeyµÈ·¢ÏÖ¿¹ÈË¿¹Ìå21M18Ñ¡ÔñÐÔÒÖÖÆ°üÀ¨HES1»ùÒòºÍATOH1»ùÒòÔÚÄÚµÄNotch°Ð»ùÒò£¬ÒÖÖÆ°Ð»ùÒòʵ¼ÊÉÏÔì³ÉÁ˶ñÐÔϸ°ûÔöֳˮƽµÍÏ¡£ ¹©²Î¿¼£¡ |

2Â¥2014-02-22 01:18:42
ÓÀÔ¶µÄNO.1
½û³æ (ÎÄ̳¾«Ó¢)
|
±¾ÌûÄÚÈݱ»ÆÁ±Î |
3Â¥2014-02-23 16:01:53














»Ø¸´´ËÂ¥